Literature DB >> 20399232

Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native protein.

Jaime Henrique Amorim1, Bruna F M M Porchia, Andrea Balan, Rafael C M Cavalcante, Simone Morais da Costa, Ada Maria de Barcelos Alves, Luís Carlos de Souza Ferreira.   

Abstract

The dengue virus NS1 protein has been shown to be a protective antigen under different experimental conditions but the recombinant protein produced in bacterial expression systems is usually not soluble and loses structural and immunological features of the native viral protein. In the present study, experimental conditions leading to purification and refolding of the recombinant dengue virus type 2 (DENV-2) NS1 protein expressed in Escherichia coli are described. The refolded recombinant protein was recovered as heat-stable soluble dimers with preserved structural features, as demonstrated by spectroscopic methods. In addition, antibodies against epitopes of the NS1 protein expressed in eukaryotic cells recognized the refolded protein expressed in E. coli but not the denatured form or the same protein submitted to a different refolding condition. Collectively, the results demonstrate that the recombinant NS1 protein preserved important conformation and antigenic determinants of the native virus protein and represents a valuable reagent either for the development of vaccines or for diagnostic methods. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399232     DOI: 10.1016/j.jviromet.2010.04.003

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  20 in total

1.  Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.

Authors:  Rosa Ramírez; Rosabel Falcón; Alienys Izquierdo; Angélica García; Mayling Alvarez; Ana Beatriz Pérez; Yudira Soto; Mayra Muné; Emiliana Mandarano da Silva; Oney Ortega; Ronaldo Mohana-Borges; María G Guzmán
Journal:  Virus Genes       Date:  2014-05-23       Impact factor: 2.332

2.  Reactivity of DENV-positive sera against recombinant envelope proteins produced in bacteria and eukaryotic cells.

Authors:  Higo Fernando Santos Souza; Arthur Baruel Zaneti; Bianca da Silva Almeida; Jéssica Amaral Martinho; Márcio Massao Yamamoto; Daniela Santoro Rosa; Renata Denzegrini Slhessarenko; Silvia Beatriz Boscardin
Journal:  Immunol Res       Date:  2022-10-03       Impact factor: 4.505

3.  Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil.

Authors:  Robert Andreata-Santos; Rafael Rahal Guaragna Machado; Rúbens Prince Dos Santos Alves; Natiely Silva Sales; Camila Pereira Soares; Karine Bitencourt Rodrigues; Mariângela Oliveira Silva; Marianna Teixeira de Pinho Favaro; Mônica Josiane Rodrigues-Jesus; Márcio Massao Yamamoto; Juliana Bannwart de Andrade; Ricardo Ambrósio Fock; Paulo Francisco Ramos Margarido; Cristiane Rodrigues Guzzo Carvalho; Silvia Beatriz Boscardin; Edison Luiz Durigon; Luís C S Ferreira
Journal:  Front Cell Infect Microbiol       Date:  2022-06-02       Impact factor: 6.073

4.  A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.

Authors:  Jaime Henrique Amorim; Raíza Sales Pereira Bizerra; Rúbens Prince dos Santos Alves; Maria Elisabete Sbrogio-Almeida; José Eduardo Levi; Margareth Lara Capurro; Luís Carlos de Souza Ferreira
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

5.  Identification of two linear B-cell epitopes from West Nile virus NS1 by screening a phage-displayed random peptide library.

Authors:  En-Cheng Sun; Jian-Nan Ma; Ni-Hong Liu; Tao Yang; Jing Zhao; Hong-Wei Geng; Ling-Feng Wang; Yong-Li Qin; Zhi-Gao Bu; Yin-Hui Yang; Ross A Lunt; Lin-Fa Wang; Dong-Lai Wu
Journal:  BMC Microbiol       Date:  2011-07-06       Impact factor: 3.605

6.  Comprehensive mapping of common immunodominant epitopes in the West Nile virus nonstructural protein 1 recognized by avian antibody responses.

Authors:  Encheng Sun; Jing Zhao; Nihong Liu; Tao Yang; Qingyuan Xu; Yongli Qin; Zhigao Bu; Yinhui Yang; Ross A Lunt; Linfa Wang; Donglai Wu
Journal:  PLoS One       Date:  2012-02-09       Impact factor: 3.240

7.  Production of recombinant nonstructural 1 protein in Escherichia coli for early detection of Japanese encephalitis virus infection.

Authors:  Nagesh K Tripathi; Jyoti S Kumar; Karttik C Biswal; P V Lakshmana Rao
Journal:  Microb Biotechnol       Date:  2012-03-27       Impact factor: 5.813

8.  Optimization of Dengue-3 recombinant NS1 protein expression in E. coli and in vitro refolding for diagnostic applications.

Authors:  T N Athmaram; Shweta Saraswat; Princi Misra; Saurabh Shrivastava; Anil K Singh; Shailendra K Verma; N Gopalan; Prativa K Behara; P V L Rao
Journal:  Virus Genes       Date:  2012-11-28       Impact factor: 2.198

9.  High-level expression of functionally active dengue-2 non-structural antigen 1 production in Escherichia coli.

Authors:  S Gowri Sankar; K J Dhanajeyan; R Paramasivan; V Thenmozhi; B K Tyagi; S John Vennison
Journal:  Biomed Res Int       Date:  2013-09-08       Impact factor: 3.411

10.  Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge.

Authors:  Hugo R Henriques; Eline V Rampazo; Antonio J S Gonçalves; Elaine C M Vicentin; Jaime H Amorim; Raquel H Panatieri; Kelly N S Amorim; Marcio M Yamamoto; Luís C S Ferreira; Ada M B Alves; Silvia B Boscardin
Journal:  PLoS Negl Trop Dis       Date:  2013-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.